Work

475P Dynamics of TROP2 expression in triple-negative breast cancer

Year: 2023

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.651

Authors: A.C. Garrido-Castro, J. Gomez Tejeda Zanudo, J. Navarro, A.M. Barkell, A. Frangieh, A. Mohammed-Abreu, M.E. Hughes, B. Binboga Kurt, R.J. Hill, T.A. King, E.A. Mittendorf, M.C. Rebelatto, D. Carroll, N.U. Lin, S.M. Tolaney, E.C. De Bruin

Institutions: Dana-Farber Cancer Institute, AstraZeneca (United Kingdom), Dana-Farber Brigham Cancer Center, AstraZeneca (United States)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Society of Clinical Oncology, Stand Up To Cancer

OpenAlex ID: W4387826006

FWCI: 0.255

Cites:

Cited by: 2

Related to: 10